Kadmon Holdings Inc (KDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The company’s pipeline encompasses investigational candidates for the treatment of moderate to severe psoriasis, idiopathic pulmonary fibrosis, and polycystic kidney disease among others. Its pipeline candidates are based on its small molecule and biologics platforms. It also develops in-licensed product candidates and technologies. The company works in partnership with various pharmaceutical and biopharmaceutical companies to advance its pipeline candidates. Kadmon is headquartered in New York, the US.
Nov 04, 2021: Kadmon provides business update and reports third quarter 2021 financial results
Sep 09, 2021: Sanofi agrees to acquire biopharma company Kadmon for $1.9bn
Aug 05, 2021: Kadmon provides business update and reports second quarter 2021 financial results
May 06, 2021: Kadmon Provides Business Update and Reports First Quarter 2021 Financial Results
Mar 04, 2021: Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The company’s pipeline encompasses investigational candidates for the treatment of moderate to severe psoriasis, idiopathic pulmonary fibrosis, and polycystic kidney disease among others. Its pipeline candidates are based on its small molecule and biologics platforms. It also develops in-licensed product candidates and technologies. The company works in partnership with various pharmaceutical and biopharmaceutical companies to advance its pipeline candidates. Kadmon is headquartered in New York, the US.
Kadmon Holdings Inc Key Recent Developments
Nov 04, 2021: Kadmon provides business update and reports third quarter 2021 financial results
Sep 09, 2021: Sanofi agrees to acquire biopharma company Kadmon for $1.9bn
Aug 05, 2021: Kadmon provides business update and reports second quarter 2021 financial results
May 06, 2021: Kadmon Provides Business Update and Reports First Quarter 2021 Financial Results
Mar 04, 2021: Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company- Kadmon Holdings Inc - Key Facts
- Kadmon Holdings Inc - Key Employees
- Kadmon Holdings Inc - Key Employee Biographies
- Kadmon Holdings Inc - Major Products and Services
- Kadmon Holdings Inc - History
- Kadmon Holdings Inc - Company Statement
- Kadmon Holdings Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Kadmon Holdings Inc - Business Description
- Kadmon Holdings Inc - Corporate Strategy
- Kadmon Holdings Inc - SWOT Analysis
- SWOT Analysis - Overview
- Kadmon Holdings Inc - Strengths
- Kadmon Holdings Inc - Weaknesses
- Kadmon Holdings Inc - Opportunities
- Kadmon Holdings Inc - Threats
- Kadmon Holdings Inc - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
- Kadmon Holdings Inc, Recent Deals Summary
- Nov 04, 2021: Kadmon provides business update and reports third quarter 2021 financial results
- Aug 05, 2021: Kadmon provides business update and reports second quarter 2021 financial results
- May 06, 2021: Kadmon Provides Business Update and Reports First Quarter 2021 Financial Results
- Mar 04, 2021: Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
- Mar 01, 2021: Kadmon Announces Appointment of Dr. Simon Cooper as Chief Medical Officer
- Nov 05, 2020: Kadmon provides business update and reports third quarter 2020 financial results
- Aug 06, 2020: Kadmon provides business update and reports second quarter 2020 financial results
- May 07, 2020: Kadmon provides business update and reports first quarter 2020 financial results
- Mar 05, 2020: Kadmon highlights recent progress and reports fourth quarter and full year 2019 financial results
- Methodology
- Ratio Definitions
- About the Publisher
List of Tables
- Kadmon Holdings Inc, Key Facts
- Kadmon Holdings Inc, Key Employees
- Kadmon Holdings Inc, Key Employee Biographies
- Kadmon Holdings Inc, Major Products and Services
- Kadmon Holdings Inc, History
- Kadmon Holdings Inc, Other Locations
- Kadmon Holdings Inc, Subsidiaries
- Kadmon Holdings Inc, Key Competitors
- Kadmon Holdings Inc, Ratios based on current share price
- Kadmon Holdings Inc, Annual Ratios
- Kadmon Holdings Inc, Interim Ratios
- Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
- Kadmon Holdings Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Kadmon Holdings Inc, Performance Chart (2016 - 2020)
- Kadmon Holdings Inc, Ratio Charts
- Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Merck & Co Inc
- Janssen Pharmaceuticals Inc
- Gilead Sciences Inc
- AbbVie Inc
